CG
ARRY

Colony Group’s Array Biopharma Inc ARRY Stock Holding History

Colony Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,320
Closed -$293K – 739
2019
Q2 		$293K Buy
+6,320
New +$177K 0.01% 610

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Colony Group's ARRY Position: Q3 2019 in Review

Colony Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 6,320 shares — an estimated $293K sold.

Colony Group first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $293K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Colony Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Colony Group sold 6,320 Array Biopharma Inc shares in Q3 2019, an estimated $293K.
  • Colony Group first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Colony Group's Array Biopharma Inc position peaked at $293K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Colony Group's 13F filing for Q3 2019, filed 26 Nov 2019.